Results 141 to 150 of about 222,790 (315)
Location Choices of the Pharmaceutical Industry in Europe after 1992 [PDF]
Differences in regulations,technical standards and national medical cultures across EU member states created a highly segmented pharmaceutical market in Europe prior to the implementation of the Single Market Programme.
Frances Ruane, Xiaoheng Zhang
core
Two‐Way Shape Memory Polymer Composite Gripper for Adaptive Robotic Applications
Advanced Materials Technologies, EarlyView.A two‐way shape memory polymer (SMP) composite is developed with intrinsic shape‐changing capability driven solely by temperature, eliminating external actuation loads. Embedding the SMP in a low‐stiffness elastomeric matrix enabled reversible transformations during heating and cooling cycles.
Aamna Hameed, Kamran Ahmed Khan
wiley +1 more source
Longitudinal Study on the Performance of U.S. Pharmaceutical Firms: The Increasing Role of Marketing
Nowadays, the U.S. pharmaceutical industry has been under thorough scrutiny. Popular press claims of intensive marketing activities that go beyond R&D, the strong increase of me-too drugs, and, at the same time, the high industry profitability have ...
Pattikawa, L.H.
core
Advanced Materials Technologies, EarlyView.This study presents a novel platform for assessing the active mechanical behavior of living cardiac microbundles through localized nanoindentation, integrated with temperature regulation and dual‐camera imaging systems. The developed system enables quantitative evaluation of dynamic micromechanics in engineered cardiac tissues in vitro, offering ...
Lihua Lou +4 more
wiley +1 more source
A host of strategic government policies including a process patent regime led to the rise of Indian pharmaceutical firms with significant process development capabilities.
Pradhan, Jaya Prakash
core
European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending [PDF]
EU countries closely regulate pharmaceutical prices whereas the U.S. does not. This paper shows how price constraints affect the profitability, stock returns, and R&D spending of EU and U.S. firms. Compared to EU firms, U.S.
John A. Vernon, Joseph H. Golec
core
The Pharmaceutical Distribution Industry in China
, 2020 This research explains the Chinese drug policy reform, specifically the drug supply or the distribution process to health care facilities. Secondary materials such as books, online articles, and journals were used to source for information during the ...
David, Ebenezer
core
Advanced Materials Technologies, EarlyView.This study presents a new biodegradable coating for titanium implants using a natural antimicrobial peptide, caerin 1.9. Applied via solvent casting, the coating offers sustained antibacterial protection and promotes healing. Tested on 3D‐printed porous titanium scaffolds, it effectively prevented infection—including against resistant bacteria—while ...
Hejie Li +7 more
wiley +1 more source
Explaining Pharmaceutical R&D Growth Rates at the Industry Level: New Perspectives and Insights
This paper uses aggregate data for the major pharmaceutical companies in the U.S. to study the rate of growth in pharmaceutical R&D intensity over the period from 1952 to 2001.
Santerre, Rexford +2 more
core
The Value of Failures in Pharmaceutical R&D [PDF]
We build a cumulative innovation model in which both success and failure provide valuable information for future research. To test this learning mechanism, we use a dataset covering outcomes of world-wide R&D projects in the pharmaceutical industry, and ...
Fabio Pammolli +3 more
core